UT- MD Anderson
Houston, Texas 77230
25 studies enrolling now · 26 studies all time
What they study most
AML, Acute Myeloid Leukemia, Advanced Solid Tumor, Anxiety, B-cell Acute Lymphoblastic Leukemia, Breast Cancer, Cervical Cancer Stigma, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Clear Cell Renal Cell Carcinoma, Cutaneous Angiosarcoma, Endometrial Cancer
Studies at this site
- Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD — Recruiting now
- Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma — Recruiting now
- Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma — Recruiting now
- Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML — Recruiting now
- Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort — Recruiting now
- Radiofrequency Ablation For Recurrent Parathyroid Carcinoma — Recruiting now
- Development Of An Endometrial Cancer Educational Tool — Starting soon
- Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL — Starting soon
- Study Of KITE-753 in R/R B-Cell ALL — Starting soon
- Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas — Starting soon
- Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum — Starting soon
- Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma — Starting soon
- Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery — Starting soon
- RISE: Reducing Cancer and HIV Stigma Through Empowerment — Starting soon
- Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines — Starting soon
- A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma — Starting soon
- A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia — Starting soon
- Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML — Starting soon
- Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer — Starting soon
- Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia — Starting soon
- OCRA Distress & Unmet Needs — Starting soon
- Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients — Starting soon
- Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers — Starting soon
- A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma — Starting soon
- A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL) — Starting soon
- NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer — Completed